Carbylan Therapeutics
Palo Alto
About Carbylan Therapeutics
Carbylan Therapeutics was founded in 2004 with worldwide headquarters currently located in Palo Alto, California. They are a clinical-stage specialty pharmaceutical company focused on the development and commercialization of proprietary combination therapies. Our vision is to deliver best-in-class therapies to large growing markets where there is a clear unmet clinical need.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $42.7M
- Funding stage: M&A
- Last round: Debt Financing (Mar 2015)
- Ticker: nasdaq:CBYL
- Website: carbylan.com
- Phone: +1-650-855-6777
Industries & Categories
Health Care, Health Diagnostics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/carbylan-therapeutics-2023971 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.